P1134: BISPECIFIC ANTI‐CD20/19 CAR‐T – ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL – INTERIM ANALYSIS RESULTS OF DALY‐II‐USA STUDY von Shah, Nirav, Maziarz, Richard, Jacobson, Caron, Isufi, Iris, Ghosh, Monalisa, Ulrickson, Matthew, Perales, Miguel‐Angel, Lunning, Matthew, Hardy, Nancy, Wijatyk, Anna, Ancukiewicz, Marek, Nallewar, Madhavi, Coleman, Kimberly, Prudner, Bethany, Eromosele, Esther, Kaleta, Remigiusz, Miklos, David

Volltext

267 Pseudoprogression patterns: Analysis from 2 independent phase-2 studies with immunotherapy for recurrent cervical cancer von O’Malley, David, Feliu, Waldo Ortuzar, Ray-Coquard, Isabelle, O’Neal, Michael, Alexandre, Jerome, Cole, Julie, Ludwig, Robert, Nallewar, Madhavi, Buell, Jennifer, Kaleta, Remigiusz, Wijatyk, Anna, Borisovskaya, Victoria

Volltext

16 - Interim Analysis of a Phase II Study of Administered Fresh Bispecific Anti-CD20/Anti-CD19 CAR T-Cell Therapy: Zamtocabtagene Autoleucel (zamto-cel) for Relapsed/ Refractory (R... von Shah, Nirav N., Maziarz, Richard T, Jacobson, Caron A., Ghosh, Monalisa, Isufi, Iris, Ulrickson, Matthew L., Perales, Miguel-Angel, Lunning, Matthew, Hardy, Dr. Nancy Maureen, Wijatyk, Anna, Ancukiewicz, Marek, Nallewar, Mrs. Madhavi, Coleman, Kimberly C., Prudner, Bethany, Eromosele, Esther, Kaleta, Remi, Miklos, David B.

Volltext

Interim Analysis of a Phase II Study of Administered Fresh Bispecific Anti-CD20/Anti-CD19 CAR T-Cell Therapy: Zamtocabtagene Autoleucel (zamto-cel) for Relapsed/ Refractory (R/R) D... von Shah, Nirav N., Maziarz, Richard T, Jacobson, Caron A., Ghosh, Monalisa, Isufi, Iris, Ulrickson, Matthew L., Perales, Miguel-Angel, Lunning, Matthew, Hardy, Dr. Nancy Maureen, Wijatyk, Anna, Ancukiewicz, Marek, Nallewar, Mrs. Madhavi, Coleman, Kimberly C., Prudner, Bethany, Eromosele, Esther, Kaleta, Remi, Miklos, David B.

Volltext